According to Viridian Therapeutics's latest financial reports the company's current revenue (TTM ) is $0.28 Million USD. In 2023 the company made a revenue of $0.31 Million USD a decrease over the revenue in the year 2022 that were of $1.77 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.